Results 71 to 80 of about 746,035 (174)

What is the incidence and clinical significance of dry eye disease in patients treated with immune checkpoint inhibitors? A systematic review and meta‐analysis of ocular immune‐related adverse events

open access: yesActa Ophthalmologica, Volume 104, Issue 6, Page e599-e614, September 2026.
Abstract Purpose Immune checkpoint inhibitors (ICIs) have transformed cancer therapy but may cause immune‐related adverse events (irAEs), including dry eye disease (DED). This study aimed to quantify the incidence of ICI‐associated DED and to evaluate factors contributing to variability across studies.
Kai‐Yang Chen   +2 more
wiley   +1 more source

EFFICACY OF CYCLOSPORINE EYE DROPS IN TREATMENT OF MEIBOMIAN GLAND DISEASE

open access: yesPakistan Armed Forces Medical Journal, 2020
Objective: To assess the efficacy of topical cyclosporine ophthalmic solution in patients with Meibomian Gland Disease. Study Design: Quasi-experimental study.
Fatima Khan   +5 more
doaj   +4 more sources

Study of meibomian gland dysfunction and hypercholesterolemia

open access: yesTNOA Journal of Ophthalmic Science and Research, 2019
Background: Hypercholesterolemia is a risk factor for ischemic heart disease and cerebrovascular disease. Increased cholesterol in the meibomian gland secretion has been considered necessary for development of meibomian gland dysfunction (MGD).
Ashwin Segi   +2 more
doaj   +1 more source

Retrospective Analysis of Survival and Adverse Effects Associated With Stereotactic Body Radiation Therapy in 12 Dogs With Hepatocellular Carcinoma

open access: yesVeterinary and Comparative Oncology, Volume 24, Issue 3, Page 485-498, September 2026.
ABSTRACT This retrospective analysis evaluated 12 dogs with hepatocellular carcinoma (HCC) who received stereotactic body radiation therapy (SBRT). Dogs received between 6 and 25 Grey (Gy) per fraction for 1–5 fractions for a total dose of 13–30 Gy. Eleven patients (92%) experienced acute adverse effects (AE), with the majority being VRTOG grade 2–3 ...
Victoria Lee Newberry   +3 more
wiley   +1 more source

Impact of lotilaner ophthalmic solution 0.25% on disease severity in patients with Demodex blepharitis and meibomian gland disease

open access: yesFrontiers in Medicine
PurposeTo evaluate the impact of lotilaner ophthalmic solution, 0.25%, compared to vehicle, on disease severity in patients with Demodex blepharitis and meibomian gland disease.MethodsThis post-hoc analysis pooled data from two prospective, randomized ...
Bridgitte Shen Lee   +4 more
doaj   +1 more source

Compounded 0.03% Tacrolimus in Cross‐Linked Hyaluronate Improves Ocular Surface Health in Dogs With Evaporative Dry Eye Disease

open access: yesVeterinary Ophthalmology, Volume 29, Issue 5, September 2026.
ABSTRACT Objective To assess the clinical effects of a compounded 0.03% tacrolimus in 0.75% cross‐linked hyaluronic acid (XHA) on tear quantity, quality, and ocular surface health in dogs with evaporative dry eye disease (EDED). Procedures Sixteen client‐owned dogs diagnosed with EDED (normal aqueous production yet reduced stability) were enrolled in ...
Lionel Sebbag   +4 more
wiley   +1 more source

Meibomian Gland Dysfunction in Type 1 Diabetic Patients

open access: yes, 2022
Purpose: To investigate meibomian gland and tear film function in patients with type 1 diabetes.Methods: This prospective study included 50 patients with type 1 diabetes and 50 healthy controls.
Eğrilmez, Emine Deniz   +4 more
core  

Repeatability of keratometry depending on tear film osmolarity

open access: yesActa Ophthalmologica, Volume 104, Issue 5, Page e530-e537, August 2026.
Abstract Purpose To determine the repeatability of keratometry and astigmatism measurements of patients depending on the tear film osmolarity using three different devices. Methods In this study, 97 eyes of 97 patients with a mean age of 64.92 ± 12.07 years received three repeated measurements with the IOLMaster 700 (Carl Zeiss Meditec, Jena, Germany),
David Schneider   +4 more
wiley   +1 more source

Epidemiology, Tear Film, and Meibomian Gland Dysfunction in Facial Palsy: A Comparative Analysis [PDF]

open access: yes
Caroline Guerrero-de Ferran, Daniel Bastán-Fabián, Alfredo del Castillo-Morales, I Jocelyn Rivera-Alvarado, Jorge E Valdez García School of Medicine, Tecnologico de Monterrey, Monterrey, NL, MéxicoCorrespondence: Jorge E Valdez García, School of Medicine,
Valdez García JE   +4 more
core  

The Association of Chronic Topical Prostaglandin Analog Use With Meibomian Gland Dysfunction

open access: yes, 2016
Purpose: To evaluate the association of long-term prostaglandin analog (PGA) use with meibomian gland dysfunction (MGD) in medically treated glaucoma ...
Murat Irkec   +9 more
core   +1 more source

Home - About - Disclaimer - Privacy